These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 31808496)
1. Novel synthesis of platinum complexes and their intracellular delivery to tumor cells by means of magnetic nanoparticles. Quarta A; Amorín M; Aldegunde MJ; Blasi L; Ragusa A; Nitti S; Pugliese G; Gigli G; Granja JR; Pellegrino T Nanoscale; 2019 Dec; 11(48):23482-23497. PubMed ID: 31808496 [TBL] [Abstract][Full Text] [Related]
2. Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions. Savino S; Marzano C; Gandin V; Hoeschele JD; Natile G; Margiotta N Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 30011897 [TBL] [Abstract][Full Text] [Related]
3. Carboplatin prodrug conjugated Fe Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730 [TBL] [Abstract][Full Text] [Related]
4. Cellular accumulation and cytotoxicity of macromolecular platinum complexes in cisplatin-resistant tumor cells. Garmann D; Warnecke A; Kalayda GV; Kratz F; Jaehde U J Control Release; 2008 Oct; 131(2):100-6. PubMed ID: 18691617 [TBL] [Abstract][Full Text] [Related]
5. An upconversion nanoplatform for simultaneous photodynamic therapy and Pt chemotherapy to combat cisplatin resistance. Ai F; Sun T; Xu Z; Wang Z; Kong W; To MW; Wang F; Zhu G Dalton Trans; 2016 Aug; 45(33):13052-60. PubMed ID: 27430044 [TBL] [Abstract][Full Text] [Related]
6. Gelatin-encapsulated iron oxide nanoparticles for platinum (IV) prodrug delivery, enzyme-stimulated release and MRI. Cheng Z; Dai Y; Kang X; Li C; Huang S; Lian H; Hou Z; Ma P; Lin J Biomaterials; 2014 Aug; 35(24):6359-68. PubMed ID: 24816364 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of mesoporous silica nanoparticle-oxaliplatin conjugates for improved anticancer drug delivery. He H; Xiao H; Kuang H; Xie Z; Chen X; Jing X; Huang Y Colloids Surf B Biointerfaces; 2014 May; 117():75-81. PubMed ID: 24632033 [TBL] [Abstract][Full Text] [Related]
8. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug. Ma L; Lin X; Li C; Xu Z; Chan CY; Tse MK; Shi P; Zhu G Inorg Chem; 2018 Mar; 57(5):2917-2924. PubMed ID: 29436828 [TBL] [Abstract][Full Text] [Related]
9. Biodegradable and pH-Responsive Acetalated Dextran (Ac-Dex) Nanoparticles for NIR Imaging and Controlled Delivery of a Platinum-Based Prodrug into Cancer Cells. Braga CB; Perli G; Becher TB; Ornelas C Mol Pharm; 2019 May; 16(5):2083-2094. PubMed ID: 30901218 [TBL] [Abstract][Full Text] [Related]
10. Polyvalent oligonucleotide gold nanoparticle conjugates as delivery vehicles for platinum(IV) warheads. Dhar S; Daniel WL; Giljohann DA; Mirkin CA; Lippard SJ J Am Chem Soc; 2009 Oct; 131(41):14652-3. PubMed ID: 19778015 [TBL] [Abstract][Full Text] [Related]
11. Targeted iron nanoparticles with platinum-(IV) prodrugs and anti-EZH2 siRNA show great synergy in combating drug resistance in vitro and in vivo. Yu C; Ding B; Zhang X; Deng X; Deng K; Cheng Z; Xing B; Jin D; Ma P; Lin J Biomaterials; 2018 Feb; 155():112-123. PubMed ID: 29175080 [TBL] [Abstract][Full Text] [Related]
13. Rational design of polyion complex nanoparticles to overcome cisplatin resistance in cancer therapy. Yang XZ; Du XJ; Liu Y; Zhu YH; Liu YZ; Li YP; Wang J Adv Mater; 2014 Feb; 26(6):931-6. PubMed ID: 24338636 [TBL] [Abstract][Full Text] [Related]
14. Imidazole modified Pt(iv) prodrug-loaded multi-stage pH responsive nanoparticles to overcome cisplatin resistance. Kang X; Wang Y; Chen Z; Wu Y; Chen H; Yang X; Yu C Chem Commun (Camb); 2020 Sep; 56(76):11271-11274. PubMed ID: 32830841 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of Pt(IV) fluorescein conjugates to investigate Pt(IV) intracellular transformations. Song Y; Suntharalingam K; Yeung JS; Royzen M; Lippard SJ Bioconjug Chem; 2013 Oct; 24(10):1733-40. PubMed ID: 23957697 [TBL] [Abstract][Full Text] [Related]
16. Platinum-loaded, selenium-doped hydroxyapatite nanoparticles selectively reduce proliferation of prostate and breast cancer cells co-cultured in the presence of stem cells. Barbanente A; Nadar RA; Esposti LD; Palazzo B; Iafisco M; van den Beucken JJJP; Leeuwenburgh SCG; Margiotta N J Mater Chem B; 2020 Apr; 8(14):2792-2804. PubMed ID: 32159578 [TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin derived monofunctional triazole-containing platinum(II) complex counteracts oxaliplatin-induced drug resistance in colorectal cancer. Li Y; Sun Z; Cui Y; Zhang H; Zhang S; Wang X; Liu S; Gao Q Bioorg Chem; 2021 Feb; 107():104636. PubMed ID: 33465670 [TBL] [Abstract][Full Text] [Related]
18. Nano-assembly of ursolic acid with platinum prodrug overcomes multiple deactivation pathways in platinum-resistant ovarian cancer. Wang Y; Luo Z; Zhou D; Wang X; Chen J; Gong S; Yu Z Biomater Sci; 2021 Jun; 9(11):4110-4119. PubMed ID: 33949442 [TBL] [Abstract][Full Text] [Related]
19. Folate-decorated and NIR-activated nanoparticles based on platinum(IV) prodrugs for targeted therapy of ovarian cancer. Sun Y; Shi T; Zhou L; Zhou Y; Sun B; Liu X J Microencapsul; 2017 Nov; 34(7):675-686. PubMed ID: 29027828 [TBL] [Abstract][Full Text] [Related]